15th World Congress on Cancer Therapy, Biomarkers & Clinical Research
Cheng Chin Kuo
National Health Research Institutes, Taiwan
Dr. Cheng-Chin Kuo has completed his PhD at the age of 30 years from National Defense Medical Center, Taipei, Taiwan and postdoctoral studies from Academia Sinica, Taipei. In 2007, he joined the National Health Research Institutes as Assistant Investigator. In 2013, he got promotion to Associate Investigator. He has published more than 34 papers in reputed journals and has been serving as an journal reviewer. His current researches are to use comparative metabolomics analysis coupled with cellular biochemical approaches and animal model to determine physiological relevance and pathophysiological connection between physiological metabolites and inflammatory diseases such as systemic inflammation, vascular diseases, and cancer.
Abstract : Endothelium-derived 5-Methoxytryptophan acts as a therapeutic biomarker for systemic inflammation